AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8198026 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) apheresis with a dextran sulfate cellulose column; pravastatin 10 mg and niacin 1,500 mg daily for some patients.
Number of subjects: 66
Study 8198026 — intervention group
Group type: COMPARATOR
Intervention: Control group (137 patients).
Number of subjects: 66
Study 8198026 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) apheresis with significant reduction of Lp(a) levels > or = 50%.
Number of subjects: 66
Study 8198026 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) apheresis with significant reduction of Lp(a) levels < 50%.
Number of subjects: 66
Study 3283916 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance ranitidine therapy (150 mg at night)
Number of subjects: 40
Study 3283916 — intervention group
Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 40
Study 31799981 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 14
Study 29368212 — intervention group
Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ)
Number of subjects: 120
Study 29368212 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 120
Study 26795938 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist empathy
Number of subjects: 700
Study 26795938 — intervention group
Group type: EXPERIMENTAL
Intervention: Social and Recreational Counseling module
Number of subjects: 700
Study 26795938 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with Cravings and Urges module
Number of subjects: 700
Study 26795938 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood Management module
Number of subjects: 700
Study 25513807 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based HIV testing and counseling (HB‐HTC)
Number of subjects: 3197
Study 25513807 — intervention group
Group type: COMPARATOR
Intervention: Mobile clinic HIV testing and counseling (MC‐HTC)
Number of subjects: 3197
Study 22466327 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanostomy tubes (Tymp)
Number of subjects: 300
Study 22466327 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanostomy tubes with adenoidectomy (TympAde)
Number of subjects: 300
Study 22466327 — intervention group
Group type: COMPARATOR
Intervention: Control group (neither intervention)
Number of subjects: 300
Study 20372175 — intervention group
Group type: EXPERIMENTAL
Intervention: Low EGCG (300 mg)
Number of subjects: 10
Study 20372175 — intervention group
Group type: EXPERIMENTAL
Intervention: High EGCG (600 mg)
Number of subjects: 10
Study 20372175 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg)
Number of subjects: 10
Study 20372175 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG/Caffeine (300 mg/200 mg)
Number of subjects: 10
Study 20372175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 18728515 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sought educational resources
Number of subjects: 0
Study 15802866 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer patients (n = 50)
Number of subjects: 66
Study 15802866 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal cancer patients (n = 16)
Number of subjects: 66
Study 15802866 — intervention group
Group type: COMPARATOR
Intervention: Control individuals (n = 40)
Number of subjects: 66
Study 12022453 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries disclosing dye (Seek)
Number of subjects: 36
Study 12022453 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries disclosing dye (Snoop)
Number of subjects: 36
Study 12022453 — intervention group
Group type: COMPARATOR
Intervention: Control (no caries disclosing dye)
Number of subjects: 36
Study 10473894 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram (0.5‐2 mg/kg/h intravenously or 2‐8 mg/kg every 2 h orally)
Number of subjects: 15
Study 9772585 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of Western and traditional Chinese medicine (Astragalus membranaceus, taurine, coenzyme Q10, antiarrhythmics)
Number of subjects: 48
Study 9772585 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (glucose‐insulin‐potassium (GIK), coenzyme Q10, antiarrhythmics)
Number of subjects: 48
Study 1305661 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal septal deformity screening
Number of subjects: 674
Study 1305661 — intervention group
Group type: COMPARATOR
Intervention: Different types of delivery
Number of subjects: 674
Study 1305661 — intervention group
Group type: COMPARATOR
Intervention: Degree of difficulty of delivery
Number of subjects: 674
Study 4055045 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 356
Study 4055045 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 356
Study 4055045 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (sub-group with Staphylococcus aureus pneumonia)
Number of subjects: 356
Study 4055045 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin (sub-group with Staphylococcus aureus pneumonia)
Number of subjects: 356
Study 30098230 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Sedation (MS)
Number of subjects: 107
Study 30098230 — intervention group
Group type: COMPARATOR
Intervention: Deep Sedation (DS)
Number of subjects: 107
Study 29116416 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial education intervention (Seeking Safety topics)
Number of subjects: 149
Study 29116416 — intervention group
Group type: COMPARATOR
Intervention: Usual prenatal care setting (Control)
Number of subjects: 149
Study 24979303 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP target <145-135 mmHg
Number of subjects: 7500
Study 24979303 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP target <135-125 mmHg
Number of subjects: 7500
Study 24979303 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP target <125 mmHg
Number of subjects: 7500
Study 24979303 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C target A (2.8-1.8 mmol/l)
Number of subjects: 7500
Study 24979303 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C target B (<1.8 mmol/l)
Number of subjects: 7500
Study 24979303 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP targets (all three)
Number of subjects: 7500
Study 22248497 — intervention group
Group type: EXPERIMENTAL
Intervention: Galactose (GAL) supplementation
Number of subjects: 0
Study 22248497 — intervention group
Group type: COMPARATOR
Intervention: Glucose-maltodextrin (GLUC) supplementation
Number of subjects: 0
Study 19675505 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering down of combined estrogen plus progestogen therapy (EPT)
Number of subjects: 81
Study 19675505 — intervention group
Group type: COMPARATOR
Intervention: Abrupt discontinuation of combined estrogen plus progestogen therapy (EPT)
Number of subjects: 81
Study 17395393 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 inhalation test (exam group)
Number of subjects: 129
Study 17395393 — intervention group
Group type: COMPARATOR
Intervention: CO2 inhalation test (non-exam group)
Number of subjects: 129
Study 17395393 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 inhalation test (both groups)
Number of subjects: 129
Study 15760959 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic polypectomy
Number of subjects: 215
Study 15760959 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic hysteroscopy and polyp biopsy
Number of subjects: 215
Study 14619265 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital at home services
Number of subjects: 0
Study 14619265 — intervention group
Group type: COMPARATOR
Intervention: Conventional hospital care
Number of subjects: 0
Study 9891943 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary stenting (Palmaz‐Schatz) after PTCA
Number of subjects: 114
Study 9891943 — intervention group
Group type: COMPARATOR
Intervention: PTCA alone (without stenting)
Number of subjects: 114
Study 7973660 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholinergic antagonist, tropicamide, placed in the eyes of patients with Alzheimer's disease
Number of subjects: 51
Study 7973660 — intervention group
Group type: COMPARATOR
Intervention: Normal elderly controls
Number of subjects: 51
Study 2637679 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine administered via buccal route (controlled release formulation)
Number of subjects: 0
Study 2637679 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine-3-glucuronide and morphine-6-glucuronide
Number of subjects: 0
Study 29910016 — intervention group
Group type: EXPERIMENTAL
Intervention: In-session commitment statements (strength, frequency, and slope of strength) made in two therapy sessions
Number of subjects: 48
Study 29910016 — intervention group
Group type: EXPERIMENTAL
Intervention: In-session commitment statements
Number of subjects: 48
Study 29910016 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological momentary assessment (EMA) commitment to abstain
Number of subjects: 48
Study 29910016 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pre-treatment commitment to abstain and increasing commitment strength across a session
Number of subjects: 48
Study 29046197 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 77
Study 29046197 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 77
Study 26046730 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary BMMC injection
Number of subjects: 120
Study 26046730 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF mobilization (10 μg/kg/day subcutaneously for 5 days)
Number of subjects: 120
Study 26046730 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of BMMC injection plus G‐CSF
Number of subjects: 120
Study 26046730 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 120
Study 23239554 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitor treatment for 6 months
Number of subjects: 0
Study 23239554 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 0
Study 21987641 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossed legs group
Number of subjects: 34
Study 18450927 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4CBT (computer-based cognitive-behavioral therapy)
Number of subjects: 77
Study 18450927 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 77
Study 16556794 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral proton pump inhibitor (pantoprazole 20 mg)
Number of subjects: 70
Study 16556794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 12967069 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthetic agent
Number of subjects: 15
Study 12967069 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure anesthesia with cotton tip applicator
Number of subjects: 15
Study 12967069 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of topical anesthetic and pressure anesthesia
Number of subjects: 15
Study 12967069 — intervention group
Group type: COMPARATOR
Intervention: No site preparation (non-placebo control)
Number of subjects: 15
Study 10741595 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid induction analgesia (RIA) conducted twice on 15 patients
Number of subjects: 30
Study 10741595 — intervention group
Group type: COMPARATOR
Intervention: Usual dressing changes in 15 control patients
Number of subjects: 30
Study 8723449 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem monotherapy
Number of subjects: 958
Study 8723449 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus amikacin combination therapy
Number of subjects: 958
Study 8480868 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin at 20, 50, 100, and 200 micrograms/kg
Number of subjects: 40
Study 3946501 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum cannula
Number of subjects: 200
Study 3946501 — intervention group
Group type: COMPARATOR
Intervention: Other cannulas
Number of subjects: 200
Study 30251977 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI-supported mental practice
Number of subjects: 55
Study 30251977 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 55
Study 26109251 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran (150 mg bid)
Number of subjects: 110
Study 26109251 — intervention group
Group type: COMPARATOR
Intervention: Phenprocoumon (INR 2-3)
Number of subjects: 110
Study 26109251 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 110
Study 26109251 — intervention group
Group type: COMPARATOR
Intervention: Phenprocoumon
Number of subjects: 110
Study 24477762 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip force with eyes open
Number of subjects: 0
Study 24477762 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip force with larger initial aperture
Number of subjects: 0
Study 24477762 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip force after aperture changes
Number of subjects: 0
Study 24477762 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip force during aperture increase
Number of subjects: 0
Study 24477762 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip force during aperture contraction
Number of subjects: 0
Study 23044498 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyl ethyl starch (HES) solution (Voluven)
Number of subjects: 92
Study 23044498 — intervention group
Group type: COMPARATOR
Intervention: 4% gelatin
Number of subjects: 92
Study 23044498 — intervention group
Group type: COMPARATOR
Intervention: Ringer's solution
Number of subjects: 92
Study 20819983 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medication plus psychosocial intervention
Number of subjects: 1268
Study 20819983 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotic medication alone
Number of subjects: 1268
Study 19033146 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored interactive sites
Number of subjects: 6451
Study 19033146 — intervention group
Group type: COMPARATOR
Intervention: Less interactive ACS site
Number of subjects: 6451
Study 19033146 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with depression
Number of subjects: 6451
Study 19033146 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants without depression
Number of subjects: 6451
Study 15863204 — intervention group
Group type: EXPERIMENTAL
Intervention: IA plus IL‐11
Number of subjects: 100
Study 15863204 — intervention group
Group type: COMPARATOR
Intervention: IA alone
Number of subjects: 100
Study 12474761 — intervention group
Group type: EXPERIMENTAL
Intervention: Medications for osteoporosis treatment
Number of subjects: 0
Study 10726111 — intervention group
Group type: EXPERIMENTAL
Intervention: High oleic acid (OA) diet (18.0 en%)
Number of subjects: 38
Study 10726111 — intervention group
Group type: EXPERIMENTAL
Intervention: High linoleic acid (LA) diet (11.5 en%)
Number of subjects: 38
Study 10726111 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual diet)
Number of subjects: 38
Study 8573640 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipyrine estimation in saliva
Number of subjects: 116
Study 8573640 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva/plasma ACCl ratio
Number of subjects: 116
Study 8573640 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between saliva and plasma APCl or APt1/2
Number of subjects: 116
Study 8573640 — intervention group
Group type: EXPERIMENTAL
Intervention: Slope of saliva/plasma APCl relationship
Number of subjects: 116
Study 8573640 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual variance in regressions
Number of subjects: 116
Study 1724102 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin (PGI2) infusion of 10 or 20 ng/kg/min
Number of subjects: 40
Study 1724102 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin substitution
Number of subjects: 40
Study 1724102 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of prostacyclin and aprotinin
Number of subjects: 40
Study 1724102 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 6991541 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral zomepirac 100 mg
Number of subjects: 159
Study 6991541 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine 16 mg
Number of subjects: 159
Study 6991541 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral zomepirac
Number of subjects: 159
Study 6991541 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine
Number of subjects: 159
Study 6991541 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 159
Study 31687992 — intervention group
Group type: EXPERIMENTAL
Intervention: Excluding pelvic examination
Number of subjects: 0
Study 31687992 — intervention group
Group type: COMPARATOR
Intervention: Including pelvic examination
Number of subjects: 0
Study 27548582 — intervention group
Group type: EXPERIMENTAL
Intervention: PLF (Posterolateral Fusion)
Number of subjects: 60
Study 27548582 — intervention group
Group type: EXPERIMENTAL
Intervention: TLIF (Transforaminal Lateral Interbody Fusion)
Number of subjects: 60
Study 27548582 — intervention group
Group type: COMPARATOR
Intervention: PLF
Number of subjects: 60
Study 27548582 — intervention group
Group type: EXPERIMENTAL
Intervention: TLIF
Number of subjects: 60
Study 26132512 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) application (AIGaAs diode, 810 nm, 100 mW, 2J/cm(2), 15 seconds per point)
Number of subjects: 30
Study 26132512 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (simulated LLLT application)
Number of subjects: 30
Study 24177006 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (QOL) assessment using stroke-specific QOL score, analyzed as a continuous variable (range 0-5)
Number of subjects: 2870
Study 24177006 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with decline in QOL over time
Number of subjects: 2870
Study 21289587 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 15 mg/kg body weight intravenously before incision
Number of subjects: 40
Study 21289587 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 40
Study 21289587 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study 19996037 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 240
Study 19996037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 19996037 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 240
Study 18334772 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint Induced Movement Therapy (CIMT)
Number of subjects: 169
Study 14733779 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hepatitis C patients
Number of subjects: 0
Study 14733779 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (NC)
Number of subjects: 0
Study 11282177 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized rhDNase (2.5 mg daily) for 3 months
Number of subjects: 21
Study 11282177 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized placebo for 3 months
Number of subjects: 21
Study 9467148 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate diagnosis and treatment
Number of subjects: 0
Study 9467148 — intervention group
Group type: COMPARATOR
Intervention: Cytological surveillance
Number of subjects: 0
Study 7953261 — intervention group
Group type: EXPERIMENTAL
Intervention: Air insufflation
Number of subjects: 200
Study 7953261 — intervention group
Group type: COMPARATOR
Intervention: Water irrigation
Number of subjects: 200
Study 2885986 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Number of subjects: 191
Study 2885986 — intervention group
Group type: COMPARATOR
Intervention: Aurothioglucose
Number of subjects: 191
Study 27526692 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia educational tools (pamphlet and video)
Number of subjects: 0
Study 27526692 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet only
Number of subjects: 0
Study 26832449 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoselective vaporization of the prostate (PVP)
Number of subjects: 120
Study 26832449 — intervention group
Group type: COMPARATOR
Intervention: Plasmakinetic resection of prostate (PKRP)
Number of subjects: 120
Study 26832449 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP
Number of subjects: 120
Study 26832449 — intervention group
Group type: COMPARATOR
Intervention: PKRP
Number of subjects: 120
Study 25119609 — intervention group
Group type: EXPERIMENTAL
Intervention: IIV3-HD (60 μg of hemagglutinin per strain)
Number of subjects: 31989
Study 25119609 — intervention group
Group type: COMPARATOR
Intervention: IIV3-SD (15 μg of hemagglutinin per strain)
Number of subjects: 31989
Study 25119609 — intervention group
Group type: EXPERIMENTAL
Intervention: IIV3-HD
Number of subjects: 31989
Study 25119609 — intervention group
Group type: COMPARATOR
Intervention: IIV3-SD
Number of subjects: 31989
Study 23181790 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 89
Study 23181790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 20736672 — intervention group
Group type: EXPERIMENTAL
Intervention: Perspective-taking instruction
Number of subjects: 608
Study 20736672 — intervention group
Group type: COMPARATOR
Intervention: Neutral instruction
Number of subjects: 608
Study 19032175 — intervention group
Group type: EXPERIMENTAL
Intervention: Clamping method with BrAC-guided adjustments to maintain stable BrAC levels of 0.6 g l(‐1)
Number of subjects: 0
Study 19032175 — intervention group
Group type: COMPARATOR
Intervention: Two-step prekinetic procedure with a target BrAC of 0.65 g l(‐1)
Number of subjects: 0
Study 15707951 — intervention group
Group type: COMPARATOR
Intervention: SNP rs348624
Number of subjects: 664
Study 15707951 — intervention group
Group type: COMPARATOR
Intervention: Haplotypes constructed from three SNPs including rs348624
Number of subjects: 664
Study 12765659 — intervention group
Group type: EXPERIMENTAL
Intervention: Homemade liquid supplement
Number of subjects: 0
Study 12765659 — intervention group
Group type: COMPARATOR
Intervention: Standard ward diet
Number of subjects: 0